trial · primary record
SB27
Non-small Cell Lung Cancer Stage IV
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 555 |
| Primary completion | 2027-08 |
| Primary endpoint | Objective response rate (ORR) at Week 24 |
| Registry ID | NCT06348199 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:26:50.140Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06348199
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.